- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00857831
Vitamin D and Calcium Study
October 2, 2012 updated by: US Department of Veterans Affairs
Vitamin D and Calcium Replacement/Supplementation in Subjects With Chronic Spinal Cord Injury
Vitamin D aids in the body's ability to absorb calcium, it is a vital component in bone formation and break down.
Reduced levels of vitamin D can indicate a vitamin deficiency and may depress serum calcium levels.
The following is a list of common causes of vitamin D deficiency: lack of dairy products, alcohol usage, elderly, lack of exposure to sunlight, individuals with reduced mobility, GI malabsorption problems, dark complexion, severe liver damage, and renal failure.
Many of these factors can be found in individuals with spinal cord injury.
SCI results in disuse bone loss after acute injury, which continues with duration of injury.
The goal of this study is to determine the effects of vitamin D and calcium supplements on calcium metabolism and vitamin D deficiency in individuals undergoing functional electrical stimulation (FES) stand retraining (SRT).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Bronx, New York, United States, 10468
- VA Medical Center, Bronx
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Spinal Cord Injury (paraplegia or quadriplegia)
- Vitamin D deficiency
- Absolute deficient Vitamin D [25(OH)D] < 16 ng/ml
- Relative deficient Vitamin D [25(OH)D] <30ng/ml - participation in the FES/SRT study at Kessler Institute for Rehabilitation
Exclusion Criteria:
- History of kidney stones
- History of bone disorders
- Currently pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Arm 1
Vitamin D & Calcium supplementation in FES
|
2000 IU/day Vitamin D3 (cholecalciferol) and 1.3 g/day calcium carbonate will be taken for 15-20 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Effects of Vitamin D and Calcium supplements on calcium metabolism and vitamin D deficiency
Time Frame: 15-20 weeks
|
15-20 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (ACTUAL)
January 1, 2012
Study Completion (ACTUAL)
August 1, 2012
Study Registration Dates
First Submitted
March 5, 2009
First Submitted That Met QC Criteria
March 5, 2009
First Posted (ESTIMATE)
March 9, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
October 3, 2012
Last Update Submitted That Met QC Criteria
October 2, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B4162C-8
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.